# Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events

> **NCT03439267** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Intermountain Health Care, Inc.** · enrollment: 5765 (actual)

## Conditions studied

- Cardiovascular Primary Prevention Strategy

## Interventions

- **COMBINATION_PRODUCT:** Coronary Artery Calcium Screening and Statin Treatment
- **OTHER:** Standard Treatment

## Key facts

- **NCT ID:** NCT03439267
- **Lead sponsor:** Intermountain Health Care, Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-03-26
- **Primary completion:** 2026-04-06
- **Final completion:** 2027-04-06
- **Target enrollment:** 5765 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03439267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03439267, "Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03439267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*